| Malignant Breast Neoplasm studied in …STUDIED_INderived200 of 12,355show all (up to 200) |
|---|
| → studied in | NCT00006421completed Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00034216recruiting Collection of Blood From Patients With Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00043472completed Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068003enrolling by invitation Harvesting Cells for Experimental Cancer Treatments · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01441089recruiting Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595957recruiting Genomic Services Research Program · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02791581NA · active not recruiting Understanding and Predicting Breast Cancer Events After Treatment · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03412877Phase 2 · recruiting Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03451383recruiting Older Breast Cancer Patients: Risk for Cognitive Decline · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03734029Phase 3 · completed Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04] · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03762733enrolling by invitation Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03865992NA · active not recruiting Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04573231Phase 2 · completed Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05007106Phase 2 · completed MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05196087recruiting Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!) · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05440929recruiting Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564377Phase 2 · recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | HER2-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05646862Phase 3 · recruiting A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05872295Phase 1 · recruiting IKS014 in Advanced Solid Tumors That Express HER2 · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05880160NA · completed Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06110793Phase 1/Phase 2 · active not recruiting A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06120283Phase 1 · recruiting BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06148038Phase 1 · recruiting CBD for Breast Cancer Primary Tumors · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06586957Phase 1 · recruiting A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06787339Phase 2 · recruiting Capecitabine in Low Risk Triple Negative Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07039474recruiting The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07152782Phase 2 · recruiting T-DXd With or Without Neratinib for HER2 Positive Breast Cancer With Brain Metastasis · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07222267Phase 1 · recruiting An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07328516enrolling by invitation Natural History Study of Early Life Exposures in Agriculture (ELEA) · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07372079Phase 2 · recruiting Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With Chemotherapy · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07380646Phase 2 · recruiting the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07391774Phase 3 · recruiting Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial · condition mapped ONTOLOGY_EXACT · 12,355 trials mapped (3,335 active) | — | — | Estrogen Receptor-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07432178Phase 3 · recruiting CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer（Cinnamon） · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07553234NA · recruiting Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer Treatment · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07619534recruiting Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07698106Phase 1/Phase 2 · not yet recruiting Enhancing ICB Efficacy Through IL-1 Inhibition in TNBC · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07704476NA · recruiting EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07844018Phase 2 · not yet recruiting ADC Based Therapy Accroding to HER2 Heterogeneous · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07844291NA · not yet recruiting A Prospective, Open-label, Randomized Trial Comparing Switch to A1811 Versus Continued THP Neoadjuvant Therapy After THP Induction in HER2-Positive Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07844473NA · recruiting Use of Magtrace Bracketing for Excision of Lesion and Sentinel Lymph Node Localization in Breast Conserving Surgery for Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07844759NA · not yet recruiting SOLIS: Single-Dose Radiotherapy With Omission of Lumpectomy for Intact Small Breast Cancers · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07844941NA · recruiting Artificial Intelligence (AI)-Based Personalized Exercise Coaching for Patients With Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02188745Phase 2 · completed ER Reactivation Therapy for Breast Cancer · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02498613Phase 2 · active not recruiting A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02945579NA · recruiting Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03568656Phase 1/Phase 2 · completed Study to Evaluate CCS1477 in Advanced Tumours · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03697577completed CDK and Body Composition Study · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03702309recruiting Liquid Biopsy Evaluation and Repository Development at Princess Margaret · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04874038Phase 3 · active not recruiting Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN) · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04981119recruiting Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05498155Phase 2 · completed Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05528133Phase 2 · recruiting Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05607849NA · completed Breast Cancer Screening Uptake: a Randomized Controlled Trial Assessing the Effect of a Decisional Aid · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05766891Phase 2/Phase 3 · recruiting Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05913713NA · completed HIIT Following Breast Cancer Chemotherapy · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06103864Phase 3 · recruiting A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05) · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06172478Phase 2 · recruiting A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06377852Phase 3 · recruiting The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06393374Phase 3 · recruiting Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06447623Phase 3 · active not recruiting Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06721065NA · recruiting A Study of Language Interpretation Solutions for People With Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06799065Phase 1/Phase 2 · recruiting First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06841354Phase 3 · recruiting A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011) · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06855524Phase 2 · recruiting Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer · condition mapped ONTOLOGY_EXACT · 12,355 trials mapped (3,335 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06966700Phase 3 · recruiting A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07007559Phase 2 · recruiting ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07054190Phase 2 · recruiting A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07066189NA · recruiting Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07179809NA · recruiting Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07419880Phase 2 · not yet recruiting Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07832279NA · recruiting 1-Week Versus 3-Week PBI · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Early Stage Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07840534NA · not yet recruiting Patient-Initiated Follow-Up for Women After Early Breast Cancer Treatment (LYSA2PIFU) · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07840599NA · not yet recruiting Fit2ThriveMB: Optimization of a Physical Activity Promotion Intervention for Metastatic Breast Cancer Patients · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07841704NA · not yet recruiting NAUTILUS-04: No Axillary Surgical Treatment in Low-Risk Clinically Node-Negative Breast Cancer Without Whole-Breast Radiotherapy - A Prospective, Randomized, Phase III, Non-inferiority Clinical Trial · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07842055completed AI-based Prognostic Factors Identification in Early-stage Invasive Lobular Breast Carcinoma · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Breast Lobular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07842614NA · completed Effect of a Brassicaceae-Enriched Diet on Menopausal Symptoms in Women With Breast Cancer Receiving Antiestrogen Therapy · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07843121NA · completed Supervised Exercise in Women With Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07843212NA · recruiting EFFECTS OF SPSIP BLOCK ON PERIOPERATİVE INFLAMMATION AND TLR4 IN BREAST CANCER SURGERY · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00295893Phase 2 · active not recruiting Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02293954NA · active not recruiting Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02390427Phase 1 · completed Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02860000Phase 2 · completed Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03220893NA · completed Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue · condition mapped ONTOLOGY_EXACT · 12,355 trials mapped (3,335 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03573648Phase 2 · active not recruiting Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03716180Phase 1 · active not recruiting DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03927768active not recruiting Abbreviated Breast MRI (AB-MRI) With Golden-angle Radial Compressed-sensing and Parallel Imaging (GRASP) · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04570956Phase 2 · terminated Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk · condition mapped ONTOLOGY_EXACT · 12,355 trials mapped (3,335 active) | — | — | Breast Lobular Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04584255Phase 2 · active not recruiting Niraparib + Dostarlimab In BRCA Mutated Breast Cancer · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05384119Phase 1 · terminated Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05412225Phase 1 · recruiting A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05444998Phase 2 · completed Neoadjuvant Inetetamab and Pyrotinib and Nab-paclitaxel for HER2+Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05708235Phase 2 · active not recruiting A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05898789NA · recruiting Virtual Rehabilitation for Cancer Survivors · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05959291NA · active not recruiting Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06018337Phase 3 · active not recruiting A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02) · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06179303Phase 2 · recruiting Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | HER2-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06251544Phase 1 · recruiting TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06522568NA · recruiting Testing a Mammography Decision Intervention in a Rural Setting · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07407920Phase 2 · recruiting Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial · condition mapped ONTOLOGY_EXACT · 12,355 trials mapped (3,335 active) | — | — | Early Stage HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07408856Phase 1 · recruiting CAN1012 in Pre-Malignant DCIS and LCIS · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Breast Lobular Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07820228completed Survival Analysis of Early Triple Negative Breast Cancer (TNBC) Women Treated With Dose Dense Sequential Adjuvant Chemotherapy · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07838649Phase 1 · not yet recruiting Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced Cardiotoxicity · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03367676Phase 2 · terminated 12 weekS Adjuvant dOcetaxel Plus trastuzumaB in Patients With Small, Node-negative, HER2-positive Breast cancER (SOBER) · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03387553early Phase 1 · completed HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04040569Phase 1 · active not recruiting A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04144907NA · recruiting Protein Needs Study · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04222413Phase 1 · recruiting Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04400695Phase 3 · recruiting A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2 · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04715958Phase 2/Phase 3 · active not recruiting SHAPE Neoadjuvant Chemotherapy Response · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04989504Phase 3 · active not recruiting Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation Related Redness and Peeling in Breast Cancer Patients Following Mastectomy · condition mapped ONTOLOGY_EXACT · 12,355 trials mapped (3,335 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06253520Phase 1 · active not recruiting Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06534918NA · recruiting Precise Oncology Interventions in Nutrition and Training (OnPoint) · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06618287Phase 1/Phase 2 · recruiting A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06999798Phase 1 · recruiting An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07085767Phase 3 · recruiting Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07185568NA · not yet recruiting IntraOperative UltraSound Guided vs Wire Guided vs Magnetic Seed Guided Breast-Conserving Surgery for Non-palpable Tumors · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07214532NA · recruiting Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Breast Ductal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07339176Phase 1/Phase 2 · recruiting Intratumoral N17350 in Advanced Solid Tumors · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07502352NA · recruiting Remotely-Delivered Cognitive Behavioral Stress Management for Breast Cancer (R-CBSM) · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07597993recruiting BEYOND Study: A Multicentre, Prospective, Observational Study of Real-world Treatment Patterns and Outcomes of Trastuzumab Deruxtecan in Patients With HR Positive, HER2-low or Ultra-low Metastatic Breast Cancer Previously Treated With Endocrine Therapy · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07711847NA · recruiting Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Breast Ductal Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07808086recruiting Role of Tumor Microbiota in the Response to Neoadjuvant Therapy in Patients Affected by Triple Negative Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07829848NA · recruiting Response-Adapted Omission of Nodal Boost In N3 Breast Cancer After Neoadjuvant Systemic Therapy · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07835698NA · not yet recruiting The Validation of ICBT Clinical Trial: Disease Stress Adjustment in Breast Cancer Patients · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836257Phase 2 · not yet recruiting A Phase II Study of Trastuzumab Deruxtecan (T-DXd) Plus Pyrotinib in HER2-Positive Advanced Breast Cancer After Progression on T-DXd · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01174121Phase 2 · recruiting Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03766009NA · active not recruiting Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04994067recruiting Intra-Operative Radiation Registry · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05422794Phase 1 · recruiting Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06058377Phase 3 · recruiting Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer · condition mapped ONTOLOGY_EXACT · 12,355 trials mapped (3,335 active) | — | — | HER2-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06085833NA · recruiting ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06714617Phase 1 · terminated Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07426913NA · recruiting Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07528768Phase 2 · not yet recruiting HEADWATERS: Gemcitabine vs Paclitaxel in Metastatic Triple-Negative Breast Cancer in Women of African Ancestry. · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07614620NA · recruiting Effect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor and in Young Women With Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07619365Phase 2 · not yet recruiting Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07770243NA · not yet recruiting AI-Based Symptom Management for Post-Treatment Breast Cancer Survivors · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07801508Phase 1 · recruiting A Study of [68Ga]Ga-DWJ155 in Adult Patients With Solid Tumors · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07833085NA · not yet recruiting CAIX-targeted PET/CT in Solid Tumors · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07833566recruiting Biopsy-site-marker in Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07833891not yet recruiting Senocohort: Identification of Predictive Biomarkers in Breast Cancer Treatment · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07835139NA · recruiting Hypofractionated vs. Conventionally Fractionated Postmastectomy Radiotherapy After Implant-Based Reconstruction · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02620852NA · recruiting Women Informed to Screen Depending on Measures of Risk (Wisdom Study) · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03357120NA · completed Circulating Tumor DNA After Neoadjuvant Chemotherapy · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03455270Phase 1 · completed G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04084730Phase 2 · recruiting Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04644068Phase 1/Phase 2 · active not recruiting Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04734262Phase 2 · active not recruiting A Phase II Study to Explore the Safety, Tolerability, and Preliminary Antitumor Activity of Sitravatinib Plus Tislelizumab or Combination With Nab-paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC) · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05377047Phase 3 · recruiting Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05550415Phase 2 · recruiting The Role of Simvastatin in The Epithelial-Mesenchymal Transition Process of Breast Cancer · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05894239Phase 3 · recruiting A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05983432Phase 1 · recruiting Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06137833NA · completed Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Neoadjuvant and Adjuvant Chemotherapy · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06411678early Phase 1 · recruiting Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07338721completed Does Ultrasound Guidance Axillary Incision Improve Sentinel Lymph Node Detection in Breast Cancer? · condition mapped ONTOLOGY_EXACT · 12,355 trials mapped (3,335 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07524855Phase 1 · recruiting A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07829900completed First-Line Dual Versus Single HER2-Targeted Therapy With Docetaxel for Advanced HER2-Positive Breast Cancer · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831460NA · completed Horse-assisted Interventions in an Oncological Centre · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831889NA · not yet recruiting Hypofractionated Radiotherapy After Breast Reconstruction for Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01334021Phase 2 · active not recruiting Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer · condition mapped ONTOLOGY_EXACT · 12,355 trials mapped (3,335 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01872260Phase 1/Phase 2 · active not recruiting Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02221700NA · active not recruiting Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast Malignancies · condition mapped ONTOLOGY_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02455791NA · active not recruiting Feasibility and Identification of Breast Cancer Patients for Potential Avoidance of Surgery · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03796559NA · recruiting Magseed Enabled Long-Term Localization of Axillary Lymph Nodes · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04038619Phase 1 · recruiting Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04090398Phase 2 · active not recruiting Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | HER2-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04524000Phase 2 · active not recruiting Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04638751suspended ARGONAUT: Stool and Blood Sample Bank for Cancer Patients · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04871139NA · active not recruiting An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer · condition mapped ONTOLOGY_EXACT · 12,355 trials mapped (3,335 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05038735Phase 3 · active not recruiting Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor. · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05161195Phase 4 · active not recruiting Roll-over Study to Allow Continued Access to Ribociclib · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06512350recruiting Identifying Patterns in the Breath of Individuals With Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06560385NA · terminated Alleviation of Alopecia in Breast Cancer Patient Using Synbiotics Formula · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06746688Phase 1 · active not recruiting A First-in-human, Clinical Trial Assessing the Safety of ES2B-C001-S01 With or Without [Adjuvant] in Patients With HER2-expressing Metastatic Breast Cancer. · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06882499NA · not yet recruiting Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07340541Phase 2 · recruiting Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07487844NA · recruiting Pulsed Electric Field Ablation for Metastatic Breast Cancer · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07631026NA · not yet recruiting Wearable Device Tracked Recovery From Autologous Breast Reconstructive Surgery · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07676383NA · recruiting Precision Navigation to Improve Community Cancer Screening Participation · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705334Phase 1 · recruiting A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07828054Phase 3 · not yet recruiting Premedication With Dexamethasone for Preventing Interstitial Lung Disease in Patients With Breast Cancer Treated With Trastuzumab Deruxtecan · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07828652not yet recruiting Real-world Treatment Outcomes and Safety of Neoadjuvant Pembrolizumab-containing Therapy in Patients With Triple-negative Breast Cancer: Korean Nationwide Multicenter Study (Pembro-Real World) · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00417495Phase 2 · completed Sentinel Lymph Node Technique in Multifocal Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00904410Phase 4 · completed Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00911911NA · completed Proteomic Signature in Breast Cancer: Correlation With Tumor Response to Neo-adjuvant Chemotherapy · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01613482Phase 3 · terminated TraStuzumAb-Radiotherapy : Impact on the Cerebral Prevention · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01658462Phase 2 · completed Phase II Study of Docetaxel +/- Nintedanib in Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02281149completed Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy: · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02704832NA · completed Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE) · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04152499Phase 1/Phase 2 · active not recruiting Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04653740NA · active not recruiting Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04889924NA · recruiting ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05763641recruiting TAD After Chemotherapy in Locally Advanced Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05782686NA · recruiting Impact of Systematic Shaving on Margins · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06339658recruiting ICG vs Blue Patent for TAD in cN1 Breast Carcinoma After Neoadjuvant Chemotherapy · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06362616NA · recruiting Preoperative Accelerated Partial Breast Irradiation in Patients With Locally Recurrent or Second Primary Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06827236Phase 1/Phase 2 · recruiting A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer · condition mapped CURATED_BROADER · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06916637recruiting Clinical Study on the Application of 18F-HER2 Affibody PET Imaging in HER2-Expressing Breast Cancer · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07020117Phase 1 · recruiting A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors · condition mapped ALIAS · 12,355 trials mapped (3,335 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07109726Phase 1/Phase 2 · recruiting A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations · condition mapped CURATED_EXACT · 12,355 trials mapped (3,335 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |